Skip to main content
. 2017 Jul 24;7:6285. doi: 10.1038/s41598-017-06731-w

Figure 4.

Figure 4

Impact of in vivo anti-inflammatory treatment on β-cell dedifferentiation. (a) Relative mRNA expression levels of isolated islets of DIO/STZ compared to DIO mice. (b) Relative mRNA expression levels of isolated islets from DIO/STZ mice ± aIL-1β treatment. (c) Relative mRNA expression levels of isolated islets from DIO/STZ mice ± salicylate treatment. (d) Relative mRNA expression levels of isolated islets from DIO/STZ mice ± aTNFα treatment. (e) Relative mRNA expression levels of isolated islets from DIO/STZ mice ± aTNFα/aIL-1β treatment. (a) n = 20 (DIO/STZ), 29 (DIO), 3 experiments, except for IL-1β and TNFα n = 5. (b) 18–20 each, 3 experiments. (c) n = 15–16 each, 2 experiments. (d) n = 7–10, 2 experiments. (e) n = 7–9, 2 experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Statistical significance (P) was determined using the two-tailed Mann-Whitney U test. All error bars denote s.e.m. DIO, diet-induced obese; DIO/STZ, diet-induced obese/streptozotocin.